GCGR and metabolic dysfunction-associated steatotic liver disease: The understanding of the gut microbiota dysbiosis as observed in NASH/NAFLD [19] on the gut-pancreas-liver axis [20] and newly established liver-a-cell axis, important for glucagon receptor (GCGR) signaling in humans [21, 22], are far from complete.